Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study.

Literature DB >> 11927504

Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study.

Celeste L Pearce¹, Nick M Makridakis, Ronald K Ross, Malcolm C Pike, Laurence N Kolonel, Brian E Henderson, Juergen K V Reichardt.

Abstract

Entities: Disease Gene Mutation

Mesh：

Substances：

Year: 2002 PMID： 11927504

Source DB: PubMed Journal: Cancer Epidemiol Biomarkers Prev ISSN： 1055-9965 Impact factor: 4.254

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set.

Authors: Jonathan Beesley; Susan J Jordan; Amanda B Spurdle; Honglin Song; Susan J Ramus; Suzanne Kruger Kjaer; Estrid Hogdall; Richard A DiCioccio; Valerie McGuire; Alice S Whittemore; Simon A Gayther; Paul D P Pharoah; Penelope M Webb; Georgia Chenevix-Trench
Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-12 Impact factor: 4.254

Review 2. A perspective on the role of estrogen in hormone-induced prostate carcinogenesis.

Authors: Maarten C Bosland
Journal: Cancer Lett Date: 2012-08-29 Impact factor: 8.679

3. Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis.

Authors: Qiaoxin Li; Yao Zhu; Jing He; Mengyun Wang; Meiling Zhu; Tingyan Shi; Lixin Qiu; Dingwei Ye; Qingyi Wei
Journal: Mol Biol Rep Date: 2013-01-01 Impact factor: 2.316

4. SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.

Authors: Christine Neslund-Dudas; Cathryn H Bock; Kristin Monaghan; Nora L Nock; James J Yang; Andrew Rundle; Deliang Tang; Benjamin A Rybicki
Journal: Prostate Date: 2007-11-01 Impact factor: 4.104

Review 5. Genetic susceptibility to prostate cancer in men of African descent: implications for global disparities in incidence and outcomes.

Authors: Charnita M Zeigler-Johnson; Elaine Spangler; Mohamed Jalloh; Serigne M Gueye; Hanna Rennert; Timothy R Rebbeck
Journal: Can J Urol Date: 2008-02 Impact factor: 1.344

Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study.

1. Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set.

Review 2. A perspective on the role of estrogen in hormone-induced prostate carcinogenesis.

3. Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis.

4. SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.

Review 5. Genetic susceptibility to prostate cancer in men of African descent: implications for global disparities in incidence and outcomes.

Review 6. Genetic variation: effect on prostate cancer.

Review 7. Genetic polymorphisms and prostate cancer risk.

8. Hormones and prostate carcinogenesis: Androgens and estrogens.

Review 9. Genetic alterations in prostate cancer.